MINNEAPOLIS – November 7, 2019 – Vireo Health International, Inc. (“Vireo” or the “Company”) (CNSX: VREO; OTCQX: VREOF), a leading physician-led, science-focused, multi-state cannabis company, today announced that it has named Bruce Linton to the role of Executive Chairman. As Executive Chairman, Mr. Linton will be actively involved in the Company’s business. He will serve on the board of directors, work closely with Vireo CEO & Founder Kyle Kingsley, M.D., and spearhead the Company’s strategic decision-making, capital markets activity and future partnerships....
Read more
Vireo Health Names Bruce Linton as Executive Chairman
Vireo Health Announces Second Quarter 2019 Financial Results
Total revenue of $7.2 million increased 70 percent year-over-year – – Voluntary share lock-up extensions approved by management and insiders – – Christian Gonzalez promoted to Vice President of enterprise-wide...
Read more
Vireo Health Expands into Puerto Rico’s Rapidly Growing Medical Cannabis Market
MINNEAPOLIS – June 20, 2019 – Vireo Health International, Inc. (“Vireo” or the “Company”) (CSE: VREO), a leading physician-led, science-focused multi-state cannabis company, today announced the acquisition of medical cannabis...
Read more
Harris Rabin, former ABInBev & Bayer leader, joins Vireo Health as Chief Marketing Officer
Rabin brings two decades of marketing and innovation experience in consumer healthcare and beverage alcohol industries NEW YORK, May 28, 2019 – Vireo Health International, Inc., a leading science-focused, multi-state...
Read more
VIREO HEALTH ANNOUNCES BOARD OF DIRECTORS
Company establishes U.S. governance standards with appointment of new directors and committees MINNEAPOLIS — May 16, 2019 – Vireo Health International, Inc. ("Vireo Health" or the "Company") (CSE: VREO), a...
Read more View More >